The Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori, Lisbon, Portugal, 12-14 September 1997: From bench to bedside and back - Report on the European Helicobacter pylori Study Group Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori

Canadian Journal of Gastroenterology

Volumn 12, Issue 6, 1998, Pages 437-446

  Thomson, A B R ^a   Chiba, N ^b   Sinclair, P ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Surrey GI Clinic   (Canada)

^c Astra Pharma Inc   (Canada)

Author keywords

Helicobacter pylori; Review; Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH; BISMUTH CITRATE; CLARITHROMYCIN; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GASTRIN; INTERLEUKIN 8; LANSOPRAZOLE; METRONIDAZOLE; MINOCYCLINE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; ROXITHROMYCIN; TETRACYCLINE; TINIDAZOLE;

APOPTOSIS; CONFERENCE PAPER; DISEASE TRANSMISSION; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; GRANULOCYTE; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; MEDICAL RESEARCH; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH LYMPHOMA; STOMACH MUCOSA; DRUG COMBINATION; DUODENUM DISEASE; EUROPE; HELICOBACTER INFECTION; MICROBIOLOGY; PATHOPHYSIOLOGY; STOMACH DISEASE;

DRUG THERAPY, COMBINATION; DUODENAL DISEASES; EUROPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; STOMACH DISEASES;

EID: 0032161471     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/358946     Document Type: Conference Paper

References (31)

1. Cammarota G, Tursi A, Montalto M, et al. Role of dental plaque in the transmission of H. pylori infection. J Clin Gastroenterol 1996;22:174-7.
2. Eaton KA, Suerbaum S, Josenhaus C, Krakowka S. Colonisation of gnotobiotic piglets by H. pylori deficient in 2 flagellin genes. Infect Immun 1996;64:2445-8.
3. Censini S, Lange C, Xiang ZY, et al. cag, a pathogenicity island of H. pylori, encodes type 1-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-53.
4. Miehlke S, Kibler K, Kim JG, et al. Allelic variation in the cagA-bearing H. pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996;91:1322-5.
5. Atherton JC. The clinical relevance of strain types of H. pylori. Gut 1997;40:701-3.
6. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of H. pylori. Gastroenterology 1997;112:92-9.
7. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of H. pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995;37:482-7.
8. Labenz J, Tillenburg B, Peitz U, Borsch G. Long-term consequences of H. pylori eradication. Clinical aspects. Scand J Gastroenterol 1996;31(Suppl 215):111-5.
9. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing H. pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
10. Lanza FL, Evans DG, Graham DY. Effect of H. pylori on the severity of gastroduodenal mucosal injury after acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991;86:735-7.
11. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WDW. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 1996;41:1583-8.
12. Rabassa AA, Goodgame R, Sutton FM, Ou CN, Rognerud C, Graham DY. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996;39:159-63.
13. Bianchi Porro GB, Parente F, Imbesi V, Montrone F, Caruso I. Role of H. pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual the therapy. Gut 1996;39:22-6.
14. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997;6:387-400.
15. Munoz N, Franceschi S. Epidemiologie du cancer gastrique. In: Megraud F, Lamouliatte H, eds. H. pylori. Paris: Elsevier Option Bio, 1998.
16. Blaser MJ, Chyou PH, Nomura A. Age at establishment of H. pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-5.
17. Rowland M, Drumm B. H. pylori infection and peptic ulcer disease in children. Curr Opin Pediatr 1995;7:554-9.
18. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83-9.
19. The Mäastricht Consensus Meeting. European Helicobacter pylori Study Group. Gut 1997;41:8-13.
20. Sonnenberg A. Cost-benefit analysis of testing for H. pylori in dyspeptic subjects. Am J Gastroenterol 1996;91:1773-7.
21. Gillen D, El-Omar E, McColl KEL. Uncomplicated dyspepsia is a very rare presentation of GI malignancy under age 55. Gut 1996;38(Suppl 1):A33.
22. Megraud F, Lehn N, Lind T, et al. The Mach 2 study. Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 1997;112:A216.
23. Hunt R, Thomson ABR, Consensus Conference participants. Canadian Helicobacter pylori Consensus Conference. Can J Gastroenterol 1998;12:31-41.
24. Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P. Association of H. pylori infection with Raynaud's phenomenon. Lancet 1996;348:966-7.
25. Gasbarrini A, Franceschi F, Gasbarrini G, Pola P. Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 1997;9:23-8.
26. Reinauer S, Megahed M, Goerz G, et al. Schonlein-Henoch purpura associated with gastric H. pylori infection. J Am Acad Dermatol 1995;33:876-9.
27. Figura N, Guarino G, Gragnoli A, et al. H. pylori infection and thyroid diseases. Gut 1996;39(Suppl):A93.
28. Kolibasova K, Tothova I, Baumgartner I, Filo V. Eradication of H. pylori as the only successful treatment in rosacea. Arch Dermatol 1996;132:1393.
29. Tebbe B, Geilen CC, Schulzke Bojarski C, Radenhausen M, Orfanos CE. H. pylori and chronic urticaria. J Am Acad Dermatol 1996;34:685-6.
30. Tosti A, Pretolani S, Figura N, et al. H. pylori and skin diseases. Gastroenterol Int (In press)
31. Oldenburg B, Diepersloot RJA, Hoekstra JBL. High seroprevalence of H. pylori in diabetes mellitus patients. Dig Dis Sci 1996;41:458-61.